Rapport Therapeutics, Inc. (RAPP)
Healthcare
Biotechnology
41.00 $
-4.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Rapport Therapeutics, Inc. (RAPP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -87 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -3.2 | -27 | -65 | -87 | |
| 0.0 | 0.1 | 0.8 | 1.0 | |
| 0.6 | 3.5 | 10 | 19 | |
| 1.5 | 2.7 | -2.4 | 3.5 | |
| 0.3 | 1.6 | 2.4 | 0.6 | |
| -5.3 | -79 | -170 | -187 | |
| – | 0.0 | 0.0 | 0.0 | |
| – | 0.0 | – | – | |
| 40 | 145 | 222 | 271 | |
| 31 | 39 | -13 | -4.2 | |
| -3.5 | -29 | -67 | -88 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.